Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by Geckom24on Dec 14, 2016 3:52pm
449 Views
Post# 25600363

Insiders buying the whole way down

Insiders buying the whole way downLooks like insiders are accumulating shares all the way down from $3. good to keep this in mind and comparing to the last large dip from February on the charts seems eerily similar to the current drop in PLI. Im hoping that 1.88 was in fact the bottom but either way im not too worried in the long run we will be easily back to $3 range

GLTA


Dec 9/16 Weaver, Gregory Direct Ownership Public market buy Common Shares USD 1.520 10,000 21.5% 56,584 Dec 7/16 Orr-Gaucher, Nancy Direct Ownership Public market buy Common Shares 2.10 5,000 3.6% 142,921 Dec 1/16 Moran, John Edward Direct Ownership Option exercise Common Shares 0.130 26,750 6.0% 473,761 Dec 1/16 Moran, John Edward Direct Ownership Option exercise Options 0.130 -26,750 -2.8% 913,426 Nov 30/16 Clulow, Kurt Stefan Victor Control or Direction Public market buy Common Shares 2.43 2,000,200 15.4% 15,026,406 Nov 30/16 Thomvest Asset Management In... Indirect Ownership Public market buy Common Shares 2.43 2,000,200 15.4% 15,026,406 Nov 29/16 Clulow, Kurt Stefan Victor Control or Direction Public market buy Common Shares 2.40 2,499,800 23.7% 13,026,206 Nov 29/16 Hakim, Raymond Manuel Direct Ownership Public market buy Common Shares USD 1.790 - 1.806 30,000 9.7% 339,000 Nov 29/16 Thomvest Asset Management In... Indirect Ownership Public market buy Common Shares 2.40 2,499,800 23.7% 13,026,206 Nov 25/16 Mnard, Louise Direct Ownership Public market buy Common Shares 2.47 10,000 6.4% 166,200 Nov 24/16 Laurin, Pierre Indirect Ownership Public market buy Common Shares 2.45 21,600 4.9% 464,964 Nov 23/16 Laurin, Pierre Indirect Ownership Public market buy Common Shares 2.48 28,400 6.8% 443,364
Bullboard Posts